ArticleEuropean heart journal. Cardiovascular pharmacotherapy2016

Cenderitide: a multivalent designer-peptide-agonist of particulate guanylyl cyclase receptors with considerable therapeutic potential in cardiorenal disease states.

Johann WojtaPubMed ↗Publisher ↗

No numbers read from the abstract.